OECD about the competition issues in the distribution of pharma products – from February 2014
http://www.oecd.org/daf/competition/competition-distribution-pharmaceuticals.htm Key findings from the discussion include:Policy-makers and enforcers need to understand the distinctive economic features of the pharmaceuticals sector thoroughly to be able to intervene in this sector.Better enforcement of regulation and of competition law, more consumer information, and greater control over the incentives provided...